HOXA13 and prostate carcinoma: When the risk locus is deleted, the loop is disrupted, resulting in HOXA13 expression and genome-wide changes in the transcriptome, including overexpression of an oncogene (GATA2) previously shown to be associated with prostate cancer [154], as shown in Fig. 4B.